News

A new study reveals that many perceived benefits of gluten-free products, such as weight control and diabetes management, are ...
Thanks for visiting Gastroenterology Advisor. We hope you’re enjoying the latest clinical news, full-length features, case studies, and more. You’ve view ...
Pfizer has made the decision to discontinue the clinical development program for danuglipron, an oral GLP-1 receptor agonist, being investigated for chronic weight management.
The prevalence of irritable bowel syndrome and chronic idiopathic constipation rose significantly during the COVID-19 pandemic.
Incidental BE was common and associated with high-risk features that were similar to or more severe than those found in BE diagnosed by traditional methods.
Hormone diets have taken off on social media as the latest weight loss trend, but their scientific validity remains ...
HealthDay News — The viability of hospital-based emergency care in the United States is at risk, according to a RAND report released April 7.
Adverse pregnancy outcomes mediate a small proportion of the association between prepregnancy obesity and CVD risk in midlife.
Overall cancer mortality rates declined from 2001-2022; cancer incidence rates decreased from 2001-2013 and stabilized through 2021.
PBGENE-HBV is designed to potentially cure chronic hepatitis B by eliminating the root cause of the virus. The Food and Drug Administration (FDA) has granted Fast Track designation to PBGENE-HBV, an ...
The FDA has approved a tablet form of Livmarli (maralixibat) for cholestatic pruritus in patients with Alagille syndrome and progressive familial intrahepatic cholestasis.
From 2000 to 2021, there was an increase in the incidence of pancreatic adenocarcinoma, which was seen in all age groups.